Physician profile
Larry Leverett
NPI 1023032034
$2,205.18
in general payments reported to CMS, 2019-2025
11 companies · $414 in 2025
The $414 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $261 · 2021: $249 · 2022: $275 · 2023: $236 · 2024: $310 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $959.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $846.36 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $436.58 | 2023-2025 | |
| Allergan, INC. | $200.42 | 2019-2022 | |
| Smith+Nephew, INC. | $149.67 | 2020 | |
| Acell, INC. | $125.10 | 2019 | |
| Sientra, INC. | $112.59 | 2019-2021 | |
| Acelrx Pharmaceuticals, INC. | $104.19 | 2021 | |
| Tepha INC | $87.05 | 2019 | |
| Galderma Laboratories, L.P. | $66.23 | 2024-2025 | |
| Apyx Medical Corporation | $39.58 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $37.41 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Leverett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.